APO-Pemetrexed pemetrexed 100 mg (as disodium) powder for injection vial

Land: Australia

Språk: engelsk

Kilde: Department of Health (Therapeutic Goods Administration)

Aktiv ingrediens:

pemetrexed disodium hemipentahydrate, Quantity: 120.8 mg (Equivalent: pemetrexed, Qty 100 mg)

Tilgjengelig fra:

Arrotex Pharmaceuticals Pty Ltd

INN (International Name):

pemetrexed disodium hemipentahydrate

Legemiddelform:

Injection, powder for

Sammensetning:

Excipient Ingredients: mannitol; hydrochloric acid; sodium hydroxide

Administreringsrute:

Intravenous Infusion

Enheter i pakken:

1

Resept typen:

(S4) Prescription Only Medicine

Indikasjoner:

Malignant Pleural Mesothelioma,Pemetrexed, in combination with cisplatin, is indicated for the treatment of patients with malignant pleural mesothelioma.,Non-Small Cell Lung Cancer (NSCLC),Pemetrexed, in combination with cisplatin, is indicated for initial treatment of patients with locally advanced or metastatic NSCLC other than predominantly squamous cell histology.,Pemetrexed, as monotherapy, is indicated for the treatment of patients with locally advanced or metastatic NSCLC other than predominantly squamous cell histology after prior platinum-based chemotherapy.

Produkt oppsummering:

Visual Identification: White to either light yellow or green-yellow powder.; Container Type: Vial; Container Material: Glass; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Autorisasjon status:

Licence status A

Autorisasjon dato:

2014-09-04